269 related articles for article (PubMed ID: 33255609)
1. Statins: HMG-CoA Reductase Inhibitors as Potential Anticancer Agents against Malignant Neoplasms in Women.
Markowska A; Antoszczak M; Markowska J; Huczyński A
Pharmaceuticals (Basel); 2020 Nov; 13(12):. PubMed ID: 33255609
[TBL] [Abstract][Full Text] [Related]
2. Statins as Repurposed Drugs in Gynecological Cancer: A Review.
Wang KH; Liu CH; Ding DC
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430409
[TBL] [Abstract][Full Text] [Related]
3. Statins and cancer.
Vallianou NG; Kostantinou A; Kougias M; Kazazis C
Anticancer Agents Med Chem; 2014 Jun; 14(5):706-12. PubMed ID: 24295174
[TBL] [Abstract][Full Text] [Related]
4. Statin use and cancer risk: a comprehensive review.
Boudreau DM; Yu O; Johnson J
Expert Opin Drug Saf; 2010 Jul; 9(4):603-21. PubMed ID: 20377474
[TBL] [Abstract][Full Text] [Related]
5. Therapy insight: Potential of statins for cancer chemoprevention and therapy.
Katz MS
Nat Clin Pract Oncol; 2005 Feb; 2(2):82-9. PubMed ID: 16264880
[TBL] [Abstract][Full Text] [Related]
6. Pleiotropic effects of HMG-CoA reductase inhibitors.
Bocan TM
Curr Opin Investig Drugs; 2002 Sep; 3(9):1312-7. PubMed ID: 12498006
[TBL] [Abstract][Full Text] [Related]
7. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
Lennernäs H; Fager G
Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173
[TBL] [Abstract][Full Text] [Related]
8. Effect of statins on breast cancer recurrence and mortality: a review.
Van Wyhe RD; Rahal OM; Woodward WA
Breast Cancer (Dove Med Press); 2017; 9():559-565. PubMed ID: 29238220
[TBL] [Abstract][Full Text] [Related]
9. The HMG-CoA reductase pathway, statins and angioprevention.
Feng C; Han A; Ye C; Xu R; Li M
Semin Ophthalmol; 2006; 21(1):29-35. PubMed ID: 16517442
[TBL] [Abstract][Full Text] [Related]
10. Unraveling the Anticancer Potential of Statins: Mechanisms and Clinical Significance.
Zaky MY; Fan C; Zhang H; Sun XF
Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835481
[TBL] [Abstract][Full Text] [Related]
11. Effects of statins on brain tumors: a review.
Afshari AR; Mollazadeh H; Henney NC; Jamialahmad T; Sahebkar A
Semin Cancer Biol; 2021 Aug; 73():116-133. PubMed ID: 32814114
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor-negative breast cancer is less likely to arise among lipophilic statin users.
Kumar AS; Benz CC; Shim V; Minami CA; Moore DH; Esserman LJ
Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1028-33. PubMed ID: 18463402
[TBL] [Abstract][Full Text] [Related]
13. Statins and breast cancer: a smoking gun or guilt by association?
Ahmed MH; Osman MM; Alokail MS
Expert Opin Drug Saf; 2006 Sep; 5(5):599-601. PubMed ID: 16907648
[TBL] [Abstract][Full Text] [Related]
14. The Role of Statins in the Prevention of Ovarian and Endometrial Cancers.
Zeleznik OA; Irvin SR; Samimi G; Trabert B
Cancer Prev Res (Phila); 2023 Apr; 16(4):191-197. PubMed ID: 37009709
[TBL] [Abstract][Full Text] [Related]
15. Functional expression of human HMG-CoA reductase in Saccharomyces cerevisiae: a system to analyse normal and mutated versions of the enzyme in the context of statin treatment.
Wysocka-Kapcinska M; Lutyk-Nadolska J; Kiliszek M; Plochocka D; Maciag M; Leszczynska A; Rytka J; Burzynska B
J Appl Microbiol; 2009 Mar; 106(3):895-902. PubMed ID: 19187128
[TBL] [Abstract][Full Text] [Related]
16. Effects of HMG-CoA reductase inhibitors on coagulation and fibrinolysis processes.
Krysiak R; Okopień B; Herman Z
Drugs; 2003; 63(17):1821-54. PubMed ID: 12921488
[TBL] [Abstract][Full Text] [Related]
17. The Impact of Statin Therapy on the Survival of Patients with Gastrointestinal Cancer.
Gachpazan M; Kashani H; Khazaei M; Hassanian SM; Rezayi M; Asgharzadeh F; Ghayour-Mobarhan M; Ferns GA; Avan A
Curr Drug Targets; 2019; 20(7):738-747. PubMed ID: 30539694
[TBL] [Abstract][Full Text] [Related]
18. Statins, stem cells, and cancer.
Gauthaman K; Fong CY; Bongso A
J Cell Biochem; 2009 Apr; 106(6):975-83. PubMed ID: 19224538
[TBL] [Abstract][Full Text] [Related]
19. Effects of HMG-CoA reductase inhibitors on skeletal muscle: are all statins the same?
Evans M; Rees A
Drug Saf; 2002; 25(9):649-63. PubMed ID: 12137559
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological actions of statins: a critical appraisal in the management of cancer.
Gazzerro P; Proto MC; Gangemi G; Malfitano AM; Ciaglia E; Pisanti S; Santoro A; Laezza C; Bifulco M
Pharmacol Rev; 2012 Jan; 64(1):102-46. PubMed ID: 22106090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
